Latest BRCA2 Stories
Forty percent of women who have a high risk of breast cancer had risk-reducing mastectomies and 45 percent had ovaries removed, British researchers said. These surgeries are widely used by carriers of BRCA1 and BRCA2 gene mutations to reduce the risk for breast and ovarian cancer.
Many women at high risk for breast or ovarian cancer are choosing to undergo surgery as a precautionary measure to decrease their cancer risk, according to a report in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research.
Patenting pure genes linked to diseases is unconstitutional and slows down research progress, civil liberties advocates claim. American Civil Liberties Union Executive Director Anthony Romero says constitutional rights to knowledge about the human body and to make pertinent healthcare decisions are at stake when private companies are allowed to hold patents on genes found responsible for diseases, CNN reported Wednesday. The ACLU and Yeshiva University's law school filed suit in U.S.
BETHESDA, Md., May 12 /PRNewswire-USNewswire/ -- The American College of Medical Genetics (ACMG) has joined the Association for Molecular Pathology, the College of American Pathologists, and the American Society for Clinical Pathology in a lawsuit filed today charging that patents on the human genes associated with breast and ovarian cancer interfere with diagnostic testing, stifle research and limit women's options regarding their health care.
Gene Patents Stifle Patient Access To Medical Care And Critical Research NEW YORK, May 12 /PRNewswire-USNewswire/ -- The American Civil Liberties Union and the Public Patent Foundation at Benjamin N.
Women whose cells harbor harmful mutations in the BRCA genes are likely to view preventive mastectomy as the best way to reduce their risk and fears of developing breast cancer, despite other, less drastic options available.
U.S. cancer researchers say they have identified an area on chromosome 6 that's strongly linked with breast cancer susceptibility in Asian women. The Vanderbilt-Ingram Cancer Center investigators led by Dr.
A gene mutation could increase the potential of aggressive tumor development in men suffering from prostate cancer, U.S. researchers say. Dr.
Men who develop prostate cancer face an increased risk of having an aggressive tumor if they carry a so-called breast cancer gene mutation, scientists from the Albert Einstein College of Medicine of Yeshiva University report in today's issue of Clinical Cancer Research. The findings could help to guide prostate-cancer patients and their physicians in choosing treatment options.
Prophylactic salpingo-oophorectomyâ€”removal of the ovaries and fallopian tubes--reduces the relative risk of breast cancer by approximately 50 percent and the risk of ovarian and fallopian tube cancer by approximately 80 percent in women who carry a mutation in the BRCA1 or BRCA2 gene, researchers report in the January 13 online issue of the Journal of the National Cancer Institute.
- An imitative word; an onomatopoetic word.